Cetuximab-conjugated iron oxide nanoparticles for cancer imaging and therapy

References

• GrandisJRSokJCSignaling through the epidermal growth factor receptor during the development of malignancyPharmacol Ther20041021374615056497
   PubMed Web of Science ®Google Scholar
• HarrisALNicholsonSSainsburyRWrightCFarndonJEpidermal growth factor receptor and other oncogenes as prognostic markersJ Natl Cancer Inst Monogr1992111811871627426
   PubMedGoogle Scholar
• AngKKBerkeyBATuXImpact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinomaCancer Res200262247350735612499279
   PubMed Web of Science ®Google Scholar
• Rubin GrandisJMelhemMFGoodingWELevels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survivalJ Natl Cancer Inst199890118248329625170
   PubMed Web of Science ®Google Scholar
• KimESKhuriFRHerbstRSEpidermal growth factor receptor biology (IMC-C225)Curr Opin Oncol200113650651311673692
   PubMed Web of Science ®Google Scholar
• Van CutsemEKohneCHHitreECetuximab and chemotherapy as initial treatment for metastatic colorectal cancerN Engl J Med2009360141408141719339720
   PubMed Web of Science ®Google Scholar
• Van CutsemEKohneCHLangICetuximab plus irinotecan, fluo-rouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation statusJ Clin Oncol201129152011201921502544
   PubMed Web of Science ®Google Scholar
• No authors listedCetuximab approved by FDA for treatment of head and neck squamous cell cancerCancer Biol Ther20065434034216808060
   PubMed Web of Science ®Google Scholar
• MendelsohnJBlockade of receptors for growth factors: an anticancer therapy – the fourth annual Joseph H Burchenal American Association for Cancer Research Clinical Research Award LectureClin Cancer Res20006374775310741693
   PubMed Web of Science ®Google Scholar
• CiardielloFTortoraGEGFR antagonists in cancer treatmentN Engl J Med2008358111160117418337605
   PubMed Web of Science ®Google Scholar
• FanZMasuiHAltasIMendelsohnJBlockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodiesCancer Res19935318432243288364927
   PubMed Web of Science ®Google Scholar
• FanZLuYWuXMendelsohnJAntibody-induced epidermal growth factor receptor dimerization mediates inhibition of autocrine proliferation of A431 squamous carcinoma cellsJ Biol Chem19942694427595276027961676
   PubMed Web of Science ®Google Scholar
• PrewettMRockwellPRockwellRFThe biologic effects of C225, a chimeric monoclonal antibody to the EGFR, on human prostate carcinomaJ Immunother Emphasis Tumor Immunol19961964194279041461
   PubMed Web of Science ®Google Scholar
• HuangS-MBockJMHarariPMEpidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neckCancer Res19995981935194010213503
   PubMed Web of Science ®Google Scholar
• HuangS-MHarariPMModulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: inhibition of damage repair, cell cycle kinetics, and tumor angiogenesisClin Cancer Res2000662166217410873065
   PubMed Web of Science ®Google Scholar
• BrunsCJHarbisonMTDavisDWEpidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanismsClin Cancer Res2000651936194810815919
   PubMed Web of Science ®Google Scholar
• PerrottePMatsumotoTInoueKAnti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude miceClin Cancer Res19995225726510037173
   PubMed Web of Science ®Google Scholar
• WuXFanZMasuiHRosenNMendelsohnJApoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulinJ Clin Invest1995954189719057706497
   PubMed Web of Science ®Google Scholar
• PengDFanZLuYDeBlasioTScherHMendelsohnJAnti-epidermal growth factor receptor monoclonal antibody 225 up-regulates p27KIP1 and induces G1 arrest in prostatic cancer cell line DU145Cancer Res19965616366636698706005
   PubMed Web of Science ®Google Scholar
• BonnerJARaischKPTrummellHQEnhanced apoptosis with combination C225/radiation treatment serves as the impetus for clinical investigation in head and neck cancersJ Clin Oncol20001821 Suppl 1S47S53
   Web of Science ®Google Scholar
• BandyopadhyayDMandalMAdamLMendelsohnJKumarRPhysical interaction between epidermal growth factor receptor and DNA-dependent protein kinase in mammalian cellsJ Biol Chem19982733156815739430697
   PubMed Web of Science ®Google Scholar
• NaramuraMGilliesSDMendelsohnJReisfeldRAMuellerBMTherapeutic potential of chimeric and murine anti-(epidermal growth factor receptor) antibodies in a metastasis model for human melanomaCancer Immunol Immunother19933753433498402738
   PubMed Web of Science ®Google Scholar
• KuraiJChikumiHHashimotoKAntibody-dependent cellular cytotoxicity mediated by cetuximab against lung cancer cell linesClin Cancer Res20071351552156117332301
   PubMed Web of Science ®Google Scholar
• CondeJBaoCCuiDBaptistaPVTianFAntibody-drug gold nanoantennas with Raman spectroscopic fingerprints for in vivo tumour theranosticsJ Control Release2014183879324704711
   PubMed Web of Science ®Google Scholar
• KarmaniLLabarDValemboisVAntibody-functionalized nanoparticles for imaging cancer: influence of conjugation to gold nanoparticles on the biodistribution of 89Zr-labeled cetuximab in miceContrast Media Mol Imaging20138540240823740810
   PubMed Web of Science ®Google Scholar
• KaoHWLinYYChenCCBiological characterization of cetuximab-conjugated gold nanoparticles in a tumor animal modelNanotechnology [serial on the Internet]. Available from: http://iopscience.iop.org/0957-4484/25/29/295102/Accessed February 28, 2015
   Google Scholar
• FerrucciJTStarkDDIron oxide-enhanced MR imaging of the liver and spleen: review of the first 5 yearsAJR Am J Roentgenol199015559439502120963
   PubMed Web of Science ®Google Scholar
• MuraSCouvreurPNanotheranostics for personalized medicineAdv Drug Deliv Rev201264131394141622728642
   PubMed Web of Science ®Google Scholar
• YuMKParkJJonSTargeting strategies for multifunctional nanopar-ticles in cancer imaging and therapyTheranostics20122134422272217
   PubMed Web of Science ®Google Scholar
• VillanuevaACaneteMRocaAGThe influence of surface functionalization on the enhanced internalization of magnetic nanoparticles in cancer cellsNanotechnology [serial on the Internet]. Available from: http://iopscience.iop.org/0957-4484/20/11/115103/Accessed February 3, 2015
   Google Scholar
• LaConteLENitinNZurkiyaOCoating thickness of magnetic iron oxide nanoparticles affects R2 relaxivityJ Magn Reson Imaging20072661634164117968941
   PubMed Web of Science ®Google Scholar
• LaurentSForgeDPortMMagnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applicationsChem Rev200810862064211018543879
   PubMed Web of Science ®Google Scholar
• PatelDLahijiAPatelSMonoclonal antibody cetuximab binds to and down-regulates constitutively activated epidermal growth factor receptor vIII on the cell surfaceAnticancer Res2007275A3355336617970081
   PubMed Web of Science ®Google Scholar
• BhattacharyyaSBhattacharyaRCurleySMcNivenMAMukherjeePNanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosisProc Natl Acad Sci U S A201010733145411454620679244
   PubMed Web of Science ®Google Scholar
• CampbellKSInventorFox Chase Cancer Center, assigneeGenetically modified human natural killer cell linesUnited States patent US831394311202012
   Google Scholar
• BailonPWonCYPEG-modified biopharmaceuticalsExpert Opin Drug Deliv20096111619236204
   PubMed Web of Science ®Google Scholar
• FuertgesFAbuchowskiAThe clinical efficacy of poly(ethylene glycol)-modified proteinsJ Control Release1990111–3139148
   Web of Science ®Google Scholar
• ZalipskySChemistry of polyethylene glycol conjugates with biologically active moleculesAdv Drug Deliv Rev1995162–3157182
   Web of Science ®Google Scholar
• PapahadjopoulosDAllenTMGabizonASterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacyProc Natl Acad Sci U S A1991882411460114641763060
   PubMed Web of Science ®Google Scholar
• LeeRJLowPSDelivery of liposomes into cultured KB cells via folate receptor-mediated endocytosisJ Biol Chem19942695319832048106354
   PubMed Web of Science ®Google Scholar
• HadjipanayisCGMachaidzeRKaluzovaMEGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastomaCancer Res201070156303631220647323
   PubMed Web of Science ®Google Scholar
• SunadaHMagunBEMendelsohnJMacLeodCLMonoclonal antibody against epidermal growth factor receptor is internalized without stimulating receptor phosphorylationProc Natl Acad Sci U S A19868311382538292424012
   PubMed Web of Science ®Google Scholar
• JaramilloMLLeonZGrotheSPaul-RocBAbulrobAO’Connor McCourtMEffect of the anti-receptor ligand-blocking 225 monoclonal antibody on EGF receptor endocytosis and sortingExp Cell Res2006312152778279016806168
   PubMed Web of Science ®Google Scholar
• FriedmanLMRinonASchechterBSynergistic down-regulation of receptor tyrosine kinases by combinations of mAbs: implications for cancer immunotherapyProc Natl Acad Sci U S A200510261915192015684082
   PubMed Web of Science ®Google Scholar
• SpanglerJBNeilJRAbramovitchSCombination antibody treatment down-regulates epidermal growth factor receptor by inhibiting endosomal recyclingProc Natl Acad Sci U S A201010730132521325720616078
   PubMed Web of Science ®Google Scholar
• SunQMingLThomasSMPUMA mediates EGFR tyrosine kinase inhibitor-induced apoptosis in head and neck cancer cellsOncogene200928242348235719421143
   PubMed Web of Science ®Google Scholar
• ZhuHCaoXAli-OsmanFKeirSLoHWEGFR and EGFRvIII interact with PUMA to inhibit mitochondrial translocalization of PUMA and PUMA-mediated apoptosis independent of EGFR kinase activityCancer Lett2010294110111020153921
   PubMed Web of Science ®Google Scholar
• WeihuaZTsanRHuangWCSurvival of cancer cells is maintained by EGFR independent of its kinase activityCancer Cell200813538539318455122
   PubMed Web of Science ®Google Scholar
• ParkEJChoiDHKimYMagnetic iron oxide nanoparticles induce autophagy preceding apoptosis through mitochondrial damage and ER stress in RAW264.7 cellsToxicol In Vitro20142881402141225086211
   PubMed Web of Science ®Google Scholar
• NaqviSSamimMAbdinMConcentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stressInt J Nanomedicine2010598398921187917
   PubMed Web of Science ®Google Scholar
• ArnoldJNWormaldMRSimRBRuddPMDwekRAThe impact of glycosylation on the biological function and structure of human immunoglobulinsAnnu Rev Immunol200725215017029568
   PubMed Web of Science ®Google Scholar